Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?
Diabetes mellitus is characterized by long standing hyperglycemia leading to numerous life-threatening complications. For type 1 diabetes mellitus, resulting from selective destruction of insulin producing cells by exaggerated immune reaction, the only effective therapy remains exogenous insulin adm...
Main Authors: | Anna Grohová, Klára Dáňová, Radek Špíšek, Lenka Palová-Jelínková |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00079/full |
Similar Items
-
Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
by: Jitka Fucikova, et al.
Published: (2019-10-01) -
Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
by: David P. Funda, et al.
Published: (2019-05-01) -
Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.
by: Anna Grohová, et al.
Published: (2020-01-01) -
Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice
by: David P. Funda, et al.
Published: (2018-02-01) -
Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms
by: Anna Grohová, et al.
Published: (2020-01-01)